FRE

FRESENIUS SE+CO.KGAA O.N.

Stock XETRA – Stock Market Prices, News & Analysis

Fresenius SE is a global healthcare group that provides products and services for dialysis, hospitals, and outpatient care.

€ 44.14
1.30 %

FRESENIUS SE+CO.KGAA O.N.

44.14
1.30 %
FRE

Fresenius SE is a global healthcare group that provides products and services for dialysis, hospitals, and outpatient care.

Price history of FRESENIUS SE+CO.KGAA O.N.
Price history of FRESENIUS SE+CO.KGAA O.N.

Performance & Momentum

6 Months 7.58 %
1 Year 29.53 %
3 Years 85.54 %
5 Years 28.08 %

Strategic Analysis

FRESENIUS SE+CO.KGAA O.N. • 2026

Fresenius SE is a global player in the healthcare sector, specializing in dialysis services and products, hospital management, and outpatient care. Its integrated economic model, combining medical equipment and care services, allows it to benefit from recurring demand and significant barriers to entry in a growing market.

Strengths
  • Strong global positioning with extensive geographical and sectoral diversification
  • Integrated offering combining medical products and care services, creating sustainable synergies
  • Sustained long-term growth demonstrating successful adaptation to sector developments
Weaknesses
  • Dependence on strict regulation in healthcare markets, particularly in Europe
  • Exposure to fluctuations in treatment costs and constraints related to the hospital sector
Momentum

The observed positive momentum reflects a favorable dynamic driven by the rebuilding of investor confidence and solid operational performance. This sustained trend reinforces the strategic appeal in a context of transition and innovation in the healthcare sector.

Similar stocks to FRESENIUS SE+CO.KGAA O.N.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone